Cargando…
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
BACKGROUND: We previously showed that activation of the bile salt nuclear receptor Farnesoid X Receptor (FXR) protects against intestinal inflammation in mice. Reciprocally, these inflammatory mediators may decrease FXR activation. We investigated whether FXR activation is repressed in the ileum and...
Autores principales: | Nijmeijer, Rian M., Gadaleta, Raffaella M., van Mil, Saskia W. C., van Bodegraven, Adriaan A., Crusius, J. Bart A., Dijkstra, Gerard, Hommes, Daan W., de Jong, Dirk J., Stokkers, Pieter C. F., Verspaget, Hein W., Weersma, Rinse K., van der Woude, C. Janneke, Stapelbroek, Janneke M., Schipper, Marguerite E. I., Wijmenga, Cisca, van Erpecum, Karel J., Oldenburg, Bas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161760/ https://www.ncbi.nlm.nih.gov/pubmed/21887309 http://dx.doi.org/10.1371/journal.pone.0023745 |
Ejemplares similares
-
Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis
por: Nijmeijer, Rian M., et al.
Publicado: (2014) -
Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021) -
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
por: Appelman, Monique D., et al.
Publicado: (2021) -
Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR)
por: Pierre, Joseph F., et al.
Publicado: (2019) -
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
por: Girisa, Sosmitha, et al.
Publicado: (2021)